InvestorsHub Logo
Followers 16
Posts 2999
Boards Moderated 2
Alias Born 09/15/2017

Re: None

Tuesday, 06/19/2018 10:05:27 AM

Tuesday, June 19, 2018 10:05:27 AM

Post# of 205136
With a little review, it appears that Arrayit is in step 11 in the FDA clearance stage.

https://www.fda.gov/downloads/drugs/resourcesforyou/consumers/ucm284393.pdf

From 1-2-18: Arrayit completes site visit and laboratory tour with a key business-to-business B2B partner and regulatory consultant regarding submission of a proprietary microarray product line to the United States Food and Drug Administration for FDA clearance https://www.fda.gov

From 3-14-18: Arrayit clinical team submits requested standard operating procedures SOPs and other documentation required for submission of a major microarray technology product to the United States Food and Drug Administration FDA for FDA regulatory clearance https://www.fda.gov

From 5-17-18: Arrayit clinical team confirms meeting with the United States Food and Drug Administration FDA to discuss FDA clearance of a major product line. The FDA is headquartered in Silver Spring Maryland USA and improves healthcare by ensuring public safety fda.gov

From 5/29/2018 Tweet: Arrayit CLIA clinical team confirms 7/2/2018 meeting with top officials at the United States Food and Drug Administration FDA headquartered in Silver Spring Maryland USA to discuss FDA regulatory clearance of a major microarray technology product line (link: https://www.fda.gov) fda.gov

Can you believe Silicon Valley biotech stock ARYC has a market cap under $40m?? Biotech companies have valuations in excess of 50-100 x earnings yet Arrayit is trading at 4x despite having FDA clearance meeting in 3 weeks. RRBB is our auditor and 10k releases could be any day now. I hope you are all seeing how much upside potential this stock has :) Get ready for another huge week, this is just the beginning :)